Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Lymphoid 1

Conditions

Lymphoma, Follicular 1

Interventions

Cyclophosphamide 344 Rituximab 309 Vincristine 159 venetoclax 156 Doxorubicin 156 fludarabine 153 Specimen Handling 152 Prednisone 150 Biopsy 122 Magnetic Resonance Spectroscopy 117 obinutuzumab 116 Lenalidomide 110 Dexamethasone 106 Cytarabine 100 ibrutinib 96 Etoposide 94 fludarabine phosphate 87 Methotrexate 86 acalabrutinib 80 zanubrutinib 73 Bendamustine Hydrochloride 72 pembrolizumab 63 blinatumomab 63 CT-P10 61 Gemcitabine 52 glofitamab 45 Nivolumab 45 Calcium Dobesilate 45 prednylidene 43 Mercaptopurine 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

perillyl alcohol × Lymphoid × 1 year × Clear all

NCT05023018 2026-03-02

NEO100 and High-Grade Meningioma

Neonc Technologies, Inc.

Phase 2 Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡